Piermont Capital Management’s Silicon Laboratories SLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-13,960
Closed -$1.25M 263
2018
Q1
$1.25M Sell
13,960
-1,320
-9% -$125K 0.42% 108
2017
Q4
$1.35M Sell
15,280
-520
-3% -$46.7K 0.44% 100
2017
Q3
$1.26M Sell
15,800
-14,759
-48% -$1.1M 0.42% 98
2017
Q2
$2.09M Buy
30,559
+6,158
+25% +$445K 0.6% 55
2017
Q1
$1.79M Sell
24,401
-270
-1% -$18.9K 0.43% 99
2016
Q4
$1.6M Sell
24,671
-490
-2% -$30.8K 0.37% 110
2016
Q3
$1.48M Buy
25,161
+2,160
+9% +$117K 0.35% 108
2016
Q2
$1.12M Buy
23,001
+14,026
+156% +$662K 0.29% 130
2016
Q1
$404K Buy
8,975
+345
+4% +$14.8K 0.13% 182
2015
Q4
$419K Buy
+8,630
New +$427K 0.13% 170
2015
Q3
Sell
-11,159
Closed -$603K 249
2015
Q2
$603K Hold
11,159
0.18% 129
2015
Q1
$567K Buy
+11,159
New +$542K 0.17% 147

Other funds holding SLAB

Piermont Capital Management's SLAB Position: Q2 2018 in Review

Piermont Capital Management sold out of Silicon Laboratories (SLAB) in Q2 2018, closing a stake of 13,960 shares — an estimated $1.25M sold.

Piermont Capital Management first reported a position in SLAB in Q1 2015 and held it in 12 quarters. The position peaked at $2.09M in Q2 2017. 249 funds tracked by Wall St. Rank hold SLAB as of Q2 2018.

  • Piermont Capital Management reported no remaining Silicon Laboratories position as of Q2 2018 after selling out during the quarter.
  • Piermont Capital Management sold 13,960 Silicon Laboratories shares in Q2 2018, an estimated $1.25M.
  • Piermont Capital Management first reported a position in Silicon Laboratories in Q1 2015 and held it in 12 quarters.
  • Piermont Capital Management's Silicon Laboratories position peaked at $2.09M in Q2 2017.
  • 249 funds tracked by Wall St. Rank held Silicon Laboratories as of Q2 2018.

Based on Piermont Capital Management's 13F filing for Q2 2018, filed 10 Aug 2018.